Initiate when Hb < 10 g/dL, and in less severe anemia (Hb > 10 g/dL and <12 g/dL), use determined by clinical circumstances; cautioned against ESA use in cancer patients not receiving chemotherapy. This evidence concerns the gene GSTM1 and anemia (phenotype).